Comparison of antioxidant effects of naringin and probucol in cholesterol-fed rabbits

被引:102
作者
Jeon, SM
Bok, SH
Jang, MK
Kim, YH
Nam, KT
Jeong, TS
Park, YB
Choi, MS
机构
[1] Kyungpook Natl Univ, Dept Food Sci & Nutr, Puk Ku, Taegu, South Korea
[2] Korea Res Inst Biosci & Biotechnol, Taejon 305333, South Korea
[3] Kyungpook Natl Univ, Dept Genet Engn, Taegu 702701, South Korea
关键词
naringin; probucol; antioxidant enzyme; lipid peroxides; mRNA expression;
D O I
10.1016/S0009-8981(01)00778-1
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: Due to the strong evidence on the involvement of active oxygen species in a variety of disorders, the role of antioxidants against oxidative stress has recently received increased attention. Methods: Twenty male rabbits were served a high-cholesterol (HC, 5 g/kg diet) diet or high-cholesterol diet supplemented with naringin (0.5 g/kg diet) or probucol (0.5 g/kg diet) for 8 weeks to compare the antioxidative effects of the citrus bioflavonoid (naringin) and antioxidative cholesterol-lowering drug (probucol). Results: The plasma thiobarbituric acid-reactive substances (TBARS) concentration was not significantly different between the groups, whereas the hepatic TBARS concentration was significantly lower in the probucol group than in both normal and HC control or naringin group. Probucol and naringin supplementation led to an increase in the hepatic superoxide dismutase (SOD) and catalase (CAT) activities, and a decrease in the hepatic mitochondrial hydrogen peroxide (H2O2) content compared to the HC-control group. However, there was no difference in the cytosolic H2O2 content or cytosolic glutathion peroxidase (GSH-Px) activity in the liver between the groups. Both naringin and probucol supplements significantly increased the plasma vitamin E concentration compared to the HC-control group. As regards the antioxidant enzyme gene expressions, naringin significantly increased the expression of three antioxidant enzyme mRNAs compared to the HC-control group, whereas probucol significantly increased the only SOD mRNA expression. Conclusions: The probucol supplement was very potent in the antioxidative defense system, whereas naringin exhibited a comparable antioxidant capacity based on increasing the gene expressions in the antioxidant enzymes, while also increasing the hepatic SOD and CAT activities, sparing plasma vitamin E, and decreasing the hepatic mitochondrial H2O2 content. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:181 / 190
页数:10
相关论文
共 48 条
  • [41] CHEMISTRY OF 2-THIOBARBITURIC ACID TEST FOR DETERMINATION OF OXIDATIVE RANCIDITY IN FOODS .2. FORMATION OF TBA-MALONALDEHYDE COMPLEX WITHOUT ACID-HEAT TREATMENT
    TARLADGIS, BG
    DUGAN, LR
    PEARSON, AM
    [J]. JOURNAL OF THE SCIENCE OF FOOD AND AGRICULTURE, 1964, 15 (09) : 602 - &
  • [42] Effect of cholesterol feeding on DNA damage in male and female Syrian hamsters
    Turley, E
    Armstrong, NC
    Wallace, JMW
    Gilmore, WS
    McKelvey-Martin, VJ
    Allen, JM
    Strain, JJ
    [J]. ANNALS OF NUTRITION AND METABOLISM, 1999, 43 (01) : 47 - 51
  • [43] In vitro and in vivo effects of naringin on cytochrome P450-dependent monooxygenase in mouse liver
    Ueng, YF
    Chang, YL
    Oda, Y
    Park, SS
    Liao, JF
    Lin, MF
    Chen, CF
    [J]. LIFE SCIENCES, 1999, 65 (24) : 2591 - 2602
  • [44] Radicals and oxidative stress in diabetes
    West, IC
    [J]. DIABETIC MEDICINE, 2000, 17 (03) : 171 - 180
  • [45] WISSLER RW, 1992, ARCH PATHOL LAB MED, V116, P1281
  • [46] Dissociation of atherogenesis from aortic accumulation of lipid hydro(pero)xides in Watanabe heritable hyperlipidemic rabbits
    Witting, P
    Pettersson, K
    Östlund-Lindqvist, AM
    Westerlund, C
    Wågberg, M
    Stocker, R
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (02) : 213 - 220
  • [47] WOLFF SP, 1994, METHOD ENZYMOL, V233, P182
  • [48] Paradoxical enhancement of atherosclerosis by probucol treatment in apolipoprotein E-deficient mice
    Zhang, SH
    Reddick, RL
    Avdievich, E
    Surles, LK
    Jones, RG
    Reynolds, JB
    Quarfordt, SH
    Maeda, N
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (12) : 2858 - 2866